Epigenetic control of macrophage polarisation and soluble mediator gene expression during inflammation

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Kapellos, Theodore S ^a   Iqbal, Asif J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DNA METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR;

CELL DIFFERENTIATION; CELL POLARITY; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MOLECULAR BIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; ANIMAL; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CHEMOKINE CCL4; CHEMOKINE CXCL10; EPIGENESIS, GENETIC; HUMANS; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-6; MACROPHAGE ACTIVATION; MACROPHAGES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84969257089     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/6591703     Document Type: Review

References (123)

1. P. J. Murray and T. A. Wynn, "Protective and pathogenic functions ofmacrophage subsets, " Nature Reviews Immunology, vol. 11, no. 11, pp. 723-737, 2011.
2. C. Varol, A. Mildner, and S. Jung, "Macrophages: development and tissue specialization, " Annual Review of Immunology, vol. 33, pp. 643-675, 2015.
3. L. C. Davies, S. J. Jenkins, J. E. Allen, and P. R. Taylor, "Tissueresident macrophages, " Nature Immunology, vol. 14, no. 10, pp. 986-995, 2013.
4. D. Gosselin, V. M. Link, C. E. Romanoski et al., "Environment drives selection and function of enhancers controlling tissuespecific macrophage identities, " Cell, vol. 159, no. 6, pp. 1327-1340, 2014.
5. E. L. Gautiar, T. Shay, J. Miller et al., "Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages, " Nature Immunology, vol. 13, no. 11, pp. 1118-1128, 2012.
6. Y. Lavin, D. Winter, R. Blecher-Gonen et al., "Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment, " Cell, vol. 159, no. 6, pp. 1312-1326, 2014.
7. Y. Okabe and R. Medzhitov, "Tissue-specific signals control reversible program of localization and functional polarization of macrophages, " Cell, vol. 157, no. 4, pp. 832-844, 2014.
8. S. Heinz, C. Benner, N. Spann et al., "Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and b cell identities, " Molecular Cell, vol. 38, no. 4, pp. 576-589, 2010.
9. L. Escoubet-Lozach, C. Benner, M. U. Kaikkonen et al., "Mechanisms establishing tlr4-responsive activation states of inflammatory response genes, " PLoS Genetics, vol. 7, no. 12, Article ID e1002401, 2011.
10. S. Ghisletti and G. Natoli, "Deciphering cis-regulatory control in inflammatory cells, " Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, vol. 368, no. 1620, Article ID 20120370, 2013.
11. S. Ghisletti, I. Barozzi, F. Mietton et al., "Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages, " Immunity, vol. 32, no. 3, pp. 317-328, 2010.
12. J. D. Stender and C. K. Glass, "Epigenomic control of the innate immune response, " Current Opinion in Pharmacology, vol. 13, no. 4, pp. 582-587, 2013.
13. A. Di Lorenzo and M. T. Bedford, "Histone arginine methylation, " FEBS Letters, vol. 585, no. 13, pp. 2024-2031, 2011.
14. X. Zhang, H. Wen, and X. Shi, "Lysine methylation: beyond histones, " Acta Biochimica et Biophysica Sinica, vol. 44, no. 1, pp. 14-27, 2012.
15. M. G. Guenther, S. S. Levine, L. A. Boyer, R. Jaenisch, and R.A. Young, "A chromatin landmark and transcription initiation at most promoters in human cells, " Cell, vol. 130, no. 1, pp. 77-88, 2007.
16. M. P. Creyghton, A. W. Cheng, G. G. Welstead et al., "Histone H3K27ac separates active from poised enhancers and predicts developmental state, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 50, pp. 21931-21936, 2010.
17. R. Ostuni and G. Natoli, "Transcriptional control of macrophage diversity and specialization, " European Journal of Immunology, vol. 41, no. 9, pp. 2486-2490, 2011.
18. N. D. Heintzman, G. C. Hon, R. D. Hawkins et al., "Histone modifications at human enhancers reflect global cell-typespecific gene expression, " Nature, vol. 459, no. 7243, pp. 108-112, 2009.
19. M. Garber, N. Yosef, A. Goren et al., "A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals, " Molecular Cell, vol. 47, no. 5, pp. 810-822, 2012.
20. F. L. Jin, Y. Li, B. Ren, and R. Natarajan, "PU.1 and C/EBPα synergistically program distinct response to NF-κB activation through establishingmonocyte specific enhancers, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 13, pp. 5290-5295, 2011.
21. R. Medzhitov and T. Horng, "Transcriptional control of the inflammatory response, "Nature Reviews Immunology, vol. 9, no. 10, pp. 692-703, 2009.
22. M.U. Kaikkonen, N. J. Spann, S. Heinz et al., "Remodeling of the enhancer landscape duringmacrophage activation is coupled to enhancer transcription, " Molecular Cell, vol. 51, no. 3, pp. 310-325, 2013.
23. G. Natoli, "Specialized chromatin patterns in the control of inflammatory gene expression, " Current Topics in Microbiology and Immunology, vol. 349, pp. 61-72, 2011.
24. S. T. Smale, "Selective transcription in response to an inflammatory stimulus, " Cell, vol. 140, no. 6, pp. 833-844, 2010.
25. D. C. Hargreaves, T. Horng, and R. Medzhitov, "Control of inducible gene expression by signal-dependent transcriptional elongation, " Cell, vol. 138, no. 1, pp. 129-145, 2009.
26. K. Adelman, M. A. Kennedy, S. Nechaev et al., "Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 43, pp. 18207-18212, 2009.
27. V. R. Ramirez-Carrozzi, D. Braas, D.M. Bhatt et al., "A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling, " Cell, vol. 138, no. 1, pp. 114-128, 2009.
28. R. Ostuni, V. Piccolo, I. Barozzi et al., "Latent enhancers activated by stimulation in differentiated cells, " Cell, vol. 152, no. 1-2, pp. 157-171, 2013.
29. G. D. Barish, R. T. Yu, M. Karunasiri et al., "Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune response, " Genes and Development, vol. 24, no. 24, pp. 2760-2765, 2010.
30. J. van den Bossche, A. E. Neele, M. A. Hoeksema et al., "Inhibiting epigenetic enzymes to improve atherogenic macrophage functions, " Biochemical and Biophysical Research Communications, vol. 455, no. 3-4, pp. 396-402, 2014.
31. H. L. Eames, D. G. Saliba, T. Krausgruber, A. Lanfrancotti, G. Ryzhakov, and I. A. Udalova, "KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages, " Immunobiology, vol. 217, no. 12, pp. 1315-1324, 2012.
32. T. C. Fang, U. Schaefer, I. Mecklenbrauker et al., "Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response, " Journal of ExperimentalMedicine, vol. 209, no. 4, pp. 661-669, 2012.
33. Y. Sang, W. Brichalli, R. R. R. Rowland, and F. Blecha, "Genome-wide analysis of antiviral signature genes in porcine macrophages at different activation statuses, " PLoS ONE, vol. 9, no. 2, Article ID e87613, 2014.
34. N.A. Kittan, R. M. Allen, A. Dhaliwal et al., "Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes, " PLoS ONE, vol. 8, no. 10, Article ID e78045, 2013.
35. L. Austenaa, I. Barozzi, A. Chronowska et al., "The histone methyltransferase Wbp7 controls macrophage function throughGPI glycolipid anchor synthesis, " Immunity, vol. 36, no. 4, pp. 572-585, 2012.
36. M. Xia, J. Liu, X. Wu et al., "Histone methyltransferase ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20, " Immunity, vol. 39, no. 3, pp. 470-481, 2013.
37. G.L. Xu, G. L. Liu, S. D. Xiong, H. Y. Liu, X. Chen, and B. Zheng, "The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α), " Journal of Biological Chemistry, vol. 290, no. 9, pp. 5414-5423, 2015.
38. J. D. Stender, G. Pascual, W. Liu et al., "Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20, " Molecular Cell, vol. 48, no. 1, pp. 28-38, 2012.
39. M. Babu, T. D. Devi, P. Makinen et al., "Differential promoter methylation of macrophage genes is associated with impaired vascular growth in ischemic muscles of hyperlipidemic and type 2 diabetic mice genome-wide promoter methylation study, " Circulation Research, vol. 117, no. 3, pp. 289-299, 2015.
40. C. Cheng, C. Huang, T.-T. Ma et al., "SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharideinduced inflammatory cytokines in macrophages, " Toxicology Letters, vol. 225, no. 3, pp. 488-497, 2014.
41. H. P. Du, J. Li, S. J. You et al., "DNA methylation in cystathionine-γ-lyase (CSE) gene promoter induced by ox-LDL in macrophages and in apoE knockout mice, " Biochemical and Biophysical Research Communications, vol. 469, no. 3, pp. 776-782, 2016.
42. X. Yang, X. Wang, D. Liu, L. Yu, B. Xue, and H. Shi, "Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b, " Molecular Endocrinology, vol. 28, no. 4, pp. 565-574, 2014.
43. D. van Essen, Y. Zhu, and S. Saccani, "A feed-forward circuit controlling inducible NF-κB target gene activation by promoter histone demethylation, " Molecular Cell, vol. 39, no. 5, pp. 750-760, 2010.
44. Y. Zhu, D. van Essen, and S. Saccani, "Cell-type-specific control of enhancer activity by H3K9 trimethylation, " Molecular Cell, vol. 46, no. 4, pp. 408-423, 2012.
45. L. Kruidenier, C.-W. Chung, Z. Cheng et al., "Aselective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response, " Nature, vol. 488, no. 7411, pp. 404-408, 2012.
46. N. D. Das, K. H. Jung, M. R. Choi, H. S. Yoon, S. H. Kim, and Y. G. Chai, "Gene networking and inflammatory pathway analysis in a JMJD3 knockdown human monocytic cell line, " Cell Biochemistry and Function, vol. 30, no. 3, pp. 224-232, 2012.
47. K. A. Gallagher, A. Joshi, W. F. Carson et al., "Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alterwound healing in type 2 diabetes, " Diabetes, vol. 64, no. 4, pp. 1420-1430, 2015.
48. Q. Yan, L. Sun, Z. Zhu, L. Wang, S. Li, and R. D. Ye, "Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages, " Cellular Signalling, vol. 26, no. 9, pp. 1783-1791, 2014.
49. Y. Tang, T. Li, J. Li et al., "Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinsons disease, " Cell Death and Differentiation, vol. 21, no. 3, pp. 369-380, 2014.
50. M. Ishii, H. Wen, C. A. S. Corsa et al., "Epigenetic regulation of the alternatively activated macrophage phenotype, " Blood, vol. 114, no. 15, pp. 3244-3254, 2009.
51. T. Satoh, O. Takeuchi, A. Vandenbon et al., "The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection, " Nature Immunology, vol. 11, no. 10, pp. 936-944, 2010.
52. Q. Zhang, K. Zhao, Q. Shen et al., "Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6, " Nature, vol. 525, no. 7569, pp. 389-393, 2015.
53. A. Chauhan, F. Z. Quenum, A. Abbas et al., "Epigeneticmodulation of microglial inflammatory gene loci in helminth-induced immune suppression: implications for immune regulation in neurocysticercosis, " ASN Neuro, vol. 7, no. 4, pp. 1-12, 2015.
54. D. Feng, N. Sangster-Guity, R. Stone et al., "Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression, " The Journal of Immunology, vol. 185, no. 10, pp. 6003-6012, 2010.
55. T. Roger, J. Lugrin, D. Le Roy et al., "Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection, " Blood, vol. 117, no. 4, pp. 1205-1217, 2011.
56. M. Mombelli, J. Lugrin, I. Rubino et al., "Histone deacetylase inhibitors impair antibacterial defenses of macrophages, " Journal of Infectious Diseases, vol. 204, no. 9, pp. 1367-1374, 2011.
57. V. Kannan, N. Brouwer, U.-K. Hanisch, T. Regen, B. J. L. Eggen, and H. W. G. M. Boddeke, "Histone deacetylase inhibitors suppress immune activation in primary mouse microglia, " Journal of Neuroscience Research, vol. 91, no. 9, pp. 1133-1142, 2013.
58. J. Lugrin, X. C. Ding, D. Le Roy et al., "Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1793, no. 11, pp. 1749-1758, 2009.
59. G. Wang, Y. Shi, X. Jiang et al., "HDACinhibition preventswhite matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 9, pp. 2853-2858, 2015.
60. M. Cabanel, C. Brand, M. C. Oliveira-Nunes et al., "Epigenetic control of macrophage shape transition towards an atypical elongated phenotype by histone deacetylase activity, " PLoS ONE, vol. 10, no. 7, Article IDe0132984, 2015.
61. R. N. Laribee and M. J. Klemsz, "Loss of PU.1 expression following inhibition of histone deacetylases, " The Journal of Immunology, vol. 167, no. 9, pp. 5160-5166, 2001.
62. N. Serrat, S. Pereira-Lopes, M. Comalada, J. Lloberas, and A. Celada, "Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages, " European Journal of Immunology, vol. 42, no. 11, pp. 3028-3037, 2012.
63. C. Wu, A. Li, Y. Leng, Y. Li, and J. Kang, "Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets, " DNA and Cell Biology, vol. 31, no. 4, pp. 592-599, 2012.
64. M. A. Halili, M. R. Andrews, L. I. Labzin et al., "Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS, " Journal of Leukocyte Biology, vol. 87, no. 6, pp. 1103-1114, 2010.
65. X. Kong, M. Fang, P. Li, F. Fang, and Y. Xu, "HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells, " Journal of Molecular and Cellular Cardiology, vol. 46, no. 3, pp. 292-299, 2009.
66. X. Chen, I. Barozzi, A. Termanini et al., "Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 42, pp. E2865-E2874, 2012.
67. M.A. Hoeksema, M. J. Gijbels, J. VandenBossche et al., "Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions, " EMBO Molecular Medicine, vol. 6, no. 9, pp. 1124-1132, 2014.
68. M. R. Shakespear, D. M. Hohenhaus, G. M. Kelly et al., "Histone deacetylase 7 promotes toll-like receptor 4-dependent proinflammatory gene expression inmacrophages, " The Journal of Biological Chemistry, vol. 288, no. 35, pp. 25362-25374, 2013.
69. Q. Cao, S. X. Rong, J. J. Repa, R. S. Clair, J. S. Parks, and N. Mishra, "Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 1871-1879, 2014.
70. S.-O. Ka, M.-Y. Song, E. J. Bae, and B.-H. Park, "Myeloid SIRT1 regulatesmacrophage infiltration and insulin sensitivity in mice fed a high-fat diet, " Journal of Endocrinology, vol. 224, no. 2, pp. 109-118, 2015.
71. Z. Shen, J. M. Ajmo, C. Q. Rogers et al., "Role of SIRT1 in regulation of LPS-or two ethanol metabolites-induced TNF-α production in cultured macrophage cell lines, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 296, no. 5, pp. G1047-G1053, 2009.
72. T. T. Schug, Q. Xu, H. Gao et al., "Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress, " Molecular and Cellular Biology, vol. 30, no. 19, pp. 4712-4721, 2010.
73. T. Yoshizaki, S. Schenk, T. Imamura et al., "SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity, " American Journal of Physiology-Endocrinology and Metabolism, vol. 298, no. 3, pp. E419-E428, 2010.
74. R. Zhang, H.-Z. Chen, J.-J. Liu et al., "SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages, "The Journal of Biological Chemistry, vol. 285, no. 10, pp. 7097-7110, 2010.
75. G. Lo Sasso, K. J. Menzies, A. Mottis et al., "SIRT2 deficiency modulatesmacrophage polarization and susceptibility to experimental colitis, " PLoSONE, vol. 9, no. 7, Article IDe103573, 2014.
76. M. J. Kim, D. W. Kim, J. H. Park et al., "PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes inmurinemacrophages, " Free Radical Biology and Medicine, vol. 63, pp. 432-445, 2013.
77. T. F. Pais, E. M. Szego, O. Marques et al., "The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation, " The EMBO Journal, vol. 32, no. 19, pp. 2603-2616, 2013.
78. A. Villagra, F. Cheng, H.-W. Wang et al., "The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance, " Nature Immunology, vol. 10, no. 1, pp. 92-100, 2009.
79. H. W. Wang, F. D. Cheng, K. Woan et al., "Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10, " The Journal of Immunology, vol. 186, no. 7, pp. 3986-3996, 2011.
80. D. Stammler, T. Eigenbrod, S. Menz et al., "Inhibition of histone deacetylases permits lipopolysaccharide-mediated secretion of bioactive IL-1 via a caspase-1-independent mechanism, " The Journal of Immunology, vol. 195, no. 11, pp. 5421-5431, 2015.
81. F. O. Martinez and S. Gordon, "The M1 and M2 paradigm of macrophage activation: time for reassessment, " F1000Prime Reports, vol. 6, article 13, 2014.
82. D. Zhou, C. Huang, Z. Lin et al., "Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways, " Cellular Signalling, vol. 26, no. 2, pp. 192-197, 2014.
83. D. Tugal, X. Liao, and M. K. Jain, "Transcriptional control of macrophage polarization, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 6, pp. 1135-1144, 2013.
84. G. Liu and E. Abraham, "MicroRNAs in immune response andmacrophage polarization, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, pp. 170-177, 2013.
85. J. W. Graff, A. M. Dickson, G. Clay, A. P. McCaffrey, and M. E. Wilson, "Identifying functional microRNAs in macrophages with polarized phenotypes, "The Journal of Biological Chemistry, vol. 287, no. 26, pp. 21816-21825, 2012.
86. G. Zhuang, C. Meng, X. Guo et al., "A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation, " Circulation, vol. 125, no. 23, pp. 2892-2903, 2012.
87. M. He, Z. Xu, T.Ding, D.-M. Kuang, and L. Zheng, "MicroRNA-155 regulates inflammatory cytokine production in tumorassociated macrophages via targeting C/EBPβ, " Cellular and Molecular Immunology, vol. 6, no. 5, pp. 343-352, 2009.
88. E. D. Ponomarev, T. Veremeyko, N. Barteneva, A. M. Krichevsky, and H. L. Weiner, "MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway, " Nature Medicine, vol. 17, no. 1, pp. 64-70, 2011.
89. R. T. Martinez-Nunez, F. Louafi, and T. Sanchez-Elsner, "The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α1 (IL13Rα1), " The Journal of Biological Chemistry, vol. 286, no. 3, pp. 1786-1794, 2011.
90. M. Etzrodt, V. Cortez-Retamozo, A. Newton et al., "Regulation of monocyte functional heterogeneity by miR-146a and Relb, " Cell Reports, vol. 1, no. 4, pp. 317-324, 2012.
91. S. Banerjee, N. Xie, H. Cui et al., "MicroRNA let-7c regulates macrophage polarization, "The Journal of Immunology, vol. 190, no. 12, pp. 6542-6549, 2013.
92. S. R. Quinn and L. A. O'Neill, "A trio of microRNAs that control Toll-like receptor signalling, " International Immunology, vol. 23, no. 7, pp. 421-425, 2011.
93. S. K. Biswas and A. Mantovani, "Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, " Nature Immunology, vol. 11, no. 10, pp. 889-896, 2010.
94. J. Xue, S. V. Schmidt, J. Sander et al., "Transcriptome-based network analysis reveals a spectrum model of human macrophage activation, " Immunity, vol. 40, no. 2, pp. 274-288, 2014.
95. A. Sica and A. Mantovani, "Macrophage plasticity and polarization: in vivo veritas, " The Journal of Clinical Investigation, vol. 122, no. 3, pp. 787-795, 2012.
96. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, "Macrophage polarization: tumor-associated macrophages as a paradigmfor polarizedM2mononuclear phagocytes, " Trends in Immunology, vol. 23, no. 11, pp. 549-555, 2002.
97. B. N. Melgert, N. H. Ten Hacken, B. Rutgers, W. Timens, D. S. Postma, and M. N. Hylkema, "More alternative activation of macrophages in lungs of asthmatic patients, " Journal of Allergy and Clinical Immunology, vol. 127, no. 3, pp. 831-833, 2011.
98. W. Noel, G. Raes, G. H. Ghassabeh, P. De Baetselier, and A. Beschin, "Alternatively activated macrophages during parasite infections, " Trends in Parasitology, vol. 20, no. 3, pp. 126-133, 2004.
99. C.N. Lumeng, J. L. Bodzin, and A. R. Saltiel, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization, " Journal of Clinical Investigation, vol. 117, no. 1, pp. 175-184, 2007.
100. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., "Obesity is associated with macrophage accumulation in adipose tissue, " The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796-1808, 2003.
101. S. Mukhopadhyay, A. S. Ramadass, A. Akoulitchev, and S. Gordon, "Formation of distinct chromatin conformation signatures epigenetically regulate macrophage activation, " International Immunopharmacology, vol. 18, no. 1, pp. 7-11, 2014.
102. M. G. Goll and T.H. Bestor, "Eukaryotic cytosinemethyltransferases, " Annual Review of Biochemistry, vol. 74, pp. 481-514, 2005.
103. A. K. Maunakea, R. P. Nagarajan, M. Bilenky et al., "Conserved role of intragenic DNA methylation in regulating alternative promoters, " Nature, vol. 466, no. 7303, pp. 253-257, 2010.
104. M. Zilbauer, T. F. Rayner, C. Clark et al., "Genome-wide methylation analyses of primary human leukocyte subsets identifies functionally important cell-type-specific hypomethylated regions, " Blood, vol. 122, no. 25, pp. e52-e60, 2013.
105. Q. Cao, X. Wang, L. Jia et al., "Inhibiting DNA methylation by 5-Aza-2′-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation, " Endocrinology, vol. 155, no. 12, pp. 4925-4938, 2014.
106. A. Das, N. D. Das, K. H. Jung et al., "Proteomic changes induced by histone demethylase JMJD3 in TNF alpha-treated human monocytic (THP-1) cells, " Molecular Immunology, vol. 56, no. 1-2, pp. 113-122, 2013.
107. H. T. Lee, S. K. Kim, S. H. Kim et al., "Transcription-related element gene expression pattern differs between microglia and macrophages during inflammation, " Inflammation Research, vol. 63, no. 5, pp. 389-397, 2014.
108. P. Przanowski, M. Dabrowski, A. Ellert-Miklaszewska et al., "The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia, " Journal of Molecular Medicine, vol. 92, no. 3, pp. 239-254, 2014.
109. F. De Santa, V. Narang, Z. H. Yap et al., "Jmjd3 contributes to the control of gene expression in LPS-activated macrophages, " The EMBO Journal, vol. 28, no. 21, pp. 3341-3352, 2009.
110. M. Tahiliani, K. P. Koh, Y. Shen et al., "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNAbyMLL partner TET1, " Science, vol. 324, no. 5929, pp.930-935, 2009.
111. W. A. Pastor, L. Aravind, and A. Rao, "TETonic shift: biological roles of TET proteins inDNAdemethylation and transcription, " Nature Reviews Molecular Cell Biology, vol. 14, no. 6, pp. 341-356, 2013.
112. M. M. Dawlaty, A. Breiling, T. Le et al., "Loss of Tet enzymes compromises proper differentiation of embryonic stem cells, " Developmental Cell, vol. 29, no. 1, pp. 102-111, 2014.
113. M. Ko, Y. Huang, A. M. Jankowska et al., "Impaired hydroxylation of 5-methylcytosine inmyeloid cancerswithmutant TET2, " Nature, vol. 468, no. 7325, pp. 839-843, 2010.
114. S. Ito, L. Shen, Q. Dai et al., "Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine, " Science, vol. 333, no. 6047, pp. 1300-1303, 2011.
115. Y.-F. He, B.-Z. Li, Z. Li et al., "Tet-mediated formation of 5-carboxylcytosine and its excision byTDGinmammalian DNA, " Science, vol. 333, no. 6047, pp. 1303-1307, 2011.
116. Y. Li, S. J. Ohms, F. M. Shannon, C. Sun, and J. Y. Fan, "IL-2 and GM-CSF are regulated by DNA demethylation during activation of T cells, B cells and macrophages, " Biochemical and Biophysical Research Communications, vol. 419, no. 4, pp. 748-753, 2012.
117. K. K. Lee and J. L. Workman, "Histone acetyltransferase complexes: one size doesnt fit all, " Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 284-295, 2007.
118. G. P. Delcuve, D. H. Khan, and J. R. Davie, "Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors, " Clinical Epigenetics, vol. 4, article 5, 2012.
119. S.-B. Han and J. K. Lee, "Anti-inflammatory effect of trichostatin-A on murine bone marrow-derived macrophages, " Archives of Pharmacal Research, vol. 32, no. 4, pp. 613-624, 2009.
120. N. Serrat, C. Sebastian, S. Pereira-Lopes, L. Valverde-Estrella, J. Lloberas, and A. Celada, "The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPβ, " The Journal of Immunology, vol. 192, no. 1, pp. 418-426, 2014.
121. Y. Jeong, R. Du, X. Zhu et al., "Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogenactivated protein kinase phosphatase-1, " Journal of Leukocyte Biology, vol. 95, no. 4, pp. 651-659, 2014.
122. S. E. Mullican, C. A. Gaddis, T. Alenghat et al., "Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation, " Genes and Development, vol. 25, no. 23, pp. 2480-2488, 2011.
123. S. Stein, C. Lohmann, N. Schäfer et al., "SIRT1 decreases Lox-1-mediated foamcell formation in atherogenesis, " EuropeanHeart Journal, vol. 31, no. 18, pp. 2301-2309, 2010.